{"product_id":"biolegend-364103","title":"Biolegend, 364103, FITC anti-BrdU Antibody, 25tests","description":"\u003cp\u003eBrdU is a uridine derivative and a structural analog of thymidine, which can be incorporated into DNA during the S-phase of a cell cycle as a substitute for thymidine. Cells can be pulse-labeled with BrdU and analyzed with antibodies against BrdU to determine the proportion of cells in the S-phase of the cell cycle during a given interval.\u003cbr\u003e\n25tests\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Mouse\u003cbr\u003e\nImmunogen: Iodouridine-conjugated ovalbumin\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography and conjugated with FITC under optimal conditions.\u003cbr\u003e\nConcentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: ICFC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: immunohistochemistry and fluorescence microscopy.\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Dolbeare F, et al. 1983. Proc. Natl. Acad. Sci. USA 80:5573. Hirota K, et al. 2007. J. Exp. Med. 204:41. Godebu E, et al. 2008. J. Immunol. 181:1798. Waskow C, et al. 2008. Nat. Immunol. 9:676.\u003cbr\u003e\nProduct Citations: Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed Shi B, et al. 2023. Food Sci Nutr. 11:3433. PubMed Mo C, et al. 2022. EMBO J. 41:e108415. PubMed Hsiao HW, et al. 2023. Biomolecules. 13: . PubMed Skalniak L, et al. 2019. FEBS J. 286:1360. PubMed Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed Endres T, et al. 2021. Molecular Cell. 81(4):830-844.e13. PubMed Skalniak L, et al. 2018. Cancers (Basel). 10:. PubMed Pettinati I, et al. 2018. Elife. 7:. PubMed Barman PK, et al. 2019. J Immunol. 202:2720. PubMed Dong S, et al. 2021. Nature. 591:117. PubMed Bainor AJ et al. 2018. Cell reports. 25(10):2797-2807 . PubMed Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed ter Huurne M, et al. 2017. Cell Stem Cell. 1.186805556. PubMed Narain A, et al. 2021. Molecular Cell. 81(15):3110-3127.e14. PubMed Geeraerts SL, et al. 2020. Molecular Cancer Therapeutics. 20(1):50-63. PubMed Katarzyna Magiera et al. 2017. Cell chemical biology. 24(4):458-470 . PubMed Chen Z, et al. 2020. Cell Death Dis. 11:180. PubMed Wells AC et al. 2017. eLife. 6 pii: e26398. PubMed Xu J, et al. 2021. Cell Death Dis. 12:381. PubMed Xu Y, et al. 2021. iScience. 24:103445. PubMed Wang X, et al. 2022. Elife. 11:. PubMed Song L, et al. 2021. J Invest Dermatol. 141:903. PubMed Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed Yang L, et al. 2021. Breast Cancer Res. 23:89. PubMed El Touny LH, et al. 2021. Oncotarget. 12:2114. PubMed Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed Qi G, et al. 2021. Am J Cancer Res. 11:389. PubMed\u003cbr\u003e\nRRID: AB_2564480 (BioLegend Cat. No. 364103) AB_2564481 (BioLegend Cat. No. 364104)\u003cbr\u003e\nStructure: Uridine derivative that can be incorporated into DNA and substitute thymidine residues.\u003cbr\u003e\nDistribution: Cells can be pulse-labeled with BrdU, which will be incorporated into DNA during the cell cycle's synthesis phase.\u003cbr\u003e\nFunction: The antibody against BrdU can be used to identify cells undergoing DNA replication during the BrdU incorporation period.\u003cbr\u003e\nBiology Area: Cell Biology, Cell Cycle\/DNA Replication, Immunology\u003cbr\u003e\nMolecular Family: Nuclear Markers\u003cbr\u003e\nAntigen References: 1. Barker JM, et al. 2013. PLoS One 8:e63692. 2. Duque A and Rakic P. 2011. J. Neurosci. 31:15205. 3. Robbins S, et al. 2011. J. Vis. Exp. 55:2855. 4. Broekhuizen CA, et al. 2010. Infect Immun. 78:954. 5. van der Wath RC, et al. 2009. PLoS One 4:e6972. 6. Dolbeare F, et al. 1985. Cytometry 6:521. 7. Gratzner HG. 1982. Science 218:474.\u003cbr\u003e\nGene ID: NA\u003cbr\u003e\nClone: 3D4\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: 5-bromodeoxyuridine, bromodeoxyuridine\u003cbr\u003e\nIsotype: Mouse IgG1, κ\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46862392557737,"sku":"364103","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/ar\/products\/biolegend-364103","provider":"Iright","version":"1.0","type":"link"}